Improving health is a driving force of economic growth. Serving unmet medical needs motivates the aspiration to provide affordable medicines that make a difference.

Health improvement is a key factor for societies' growth. Cephalon wishes to contribute to this demanding challenge.

In the late 1990s, Cephalon began its growth in Europe by aiming at treating disabling sleep disorders which until then had not been taken care of. Today, Cephalon is bringing innovative solutions in several areas such as breakthrough cancer pain, metastatic breast cancer and severe types of leukaemia.

In the Maghreb and French-speaking African countries, Cephalon is making the most of the long-term partnerships that the French Lafon Laboratories intitiated 40 years ago with local pharmaceutical companies to fight spasmodic pain. These countries as well as South Africa and Middle-East are new territories of expansion for Cephalon with the increasing demand of the populations for advanced therapies in cancer and pain.

Innovation is fueling our day-to-day practices and our ambition to improve patients' lives.

WE ARE DRIVEN

Our mission is to discover and develop innovative drugs to improve patients’ lives. In Europe, Middle East and Africa Cephalon is bringing therapeutic solutions for neurological diseases, sleep disorders, pain and cancer.